AZ’ experimental asthma drug fails in Phase III

2nd November 2017 Uncategorised 0

An experimental therapy being developed by AstraZeneca and its biologics research and development arm MedImmune has failed to hit key targets in two Phase III trials.

More: AZ’ experimental asthma drug fails in Phase III
Source: News